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Abstract Diabetes mellitus (DM) patients are at an increased risk of acute myocardial infarction (AMI). Adequate
DM control may reduce in-hospital mortality and cardio-pulmonary complications after an AMI. The objective of
this study was to determine whether uncontrolled DM in patients with an incidental AMI was associated with an
increased risk of in-hospital mortality and selected cardio-pulmonary complications. A secondary data analysis of
the Puerto Rican Cardiovascular Surveillance System during 2007, 2009, and 2011 was conducted. The study
included men and women living in Puerto Rico who were hospitalized due to an incidental AMI and had information
on HbA1c measurement (n=220). Patients were divided according to their HbA1c levels into two groups (i) <7%
(controlled); and (ii) >7% (uncontrolled). Mortality and complications were defined according to ICD-9 codes.
Univariate and multivariate logistic regression models were used to test for associations between HbA1c and
mortality and cardio-pulmonary outcomes. The model was adjusted for gender, obesity (BMI >30kg/m2),
hyperlipidemia, hypertension, chronic obstructive pulmonary disease, smoking, insurance and age. The results
revealed no statistically significant association between the controlled and the uncontrolled DM patients and
mortality, respectively cardiopulmonary complications (unadjusted OR 2.1; 95% CI: 0.7-6.4; adjusted OR 2.4; 95%
CI: 0.5-10.5). The uncontrolled DM group was statistically significantly younger than those with controlled DM
(mean age 65.2 vs. 71.1 years; p-value 0.002). There was no statistically significant difference in the prevalence of
uncontrolled DM between patients with complications (80%) and those without complication (66%; p=value 0.203).
AMI patients with uncontrolled DM did not have an increased risk of mortality and cardiopulmonary complications
compared to patients with controlled DM. This needs further evaluation in a larger study population and DM
patients with an AMI should have HbA1c measured to estimate their risk of complications.
Keywords: Diabetes, acute myocardial infarction, mortality, cardiopulmonary complications, glycosylated
hemoglobin (HbA1c)
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1. Introduction
Diabetes mellitus (DM) is a growing epidemic that has
affected people from all regions and has become a rising
global burden [1]. It has affected the health condition of
millions as well as developed into a financial liability
internationally. In 2015 there was an estimated 415
million people with DM and over 5 millions deaths due to
the disease [1,2]. This chronic condition seems to affect
all systems of the body, but the most common cause of
death and disability was due to cardiovascular disease [1].

People with DM have a higher prevalence of coronary
artery disease (CAD) leading to an increased risk of
myocardial infarction (MI), mortality, and other
cardiopulmonary complications. The National Cholesterol
Education Program report from the United States and
European guidelines consider DM to be a coronary heart
disease (CHD) equivalent, thereby elevating it to the
highest risk category [1]. This classification was based on
coronary mortality for patients with DM without a prior
MI and patients without DM who had a prior MI [2].
According to the American Diabetes Association (ADA)
[4], the assessment of HbA1c levels in diabetes patients are
categorized as good control (<7%), suboptimal control
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(HbA1c 7% to 9%), or poor control (HbA1c >9%)4. Poor
long-term glycemic control is an important risk factor for
adverse outcomes in patients with DM [4]. Epidemiologic
studies suggest that an increase in HbA1c of 1% is
associated with a 20% increased risk in subsequent
mortality for patients with coronary disease and
concurrent DM [4]. Information regarding associations
between DM control and 30 days in-hospital survival are
contradictory [5,8,9]. Previous studies had controversial
results with several limitations that included selection bias
[6], small sample size causing low power to detect
differences, and focus on special subgroups of the
population [12].
The aim of our study was to investigate whether
diabetes control was associated with mortality and
cardiopulmonary complications such as atrial fibrillation,
ventricular tachycardia, ventricular fibrillation, cardiac
arrest, pulmonary infarction, pulmonary edema,
respiratory failure, and stroke in DM patient with an
incident AMI in Puerto Rico.

2. Materials and Methods
2.1. Study Design
We conducted a cross-sectional study of the Puerto
Rican Cardiovascular Surveillance database during 2007,
2009 and 2011 [10].

2.2. Study Population
All previous health records were reviewed before
including a patient. The definition used in this study as
inclusion criteria for T2DM was previous history of DM
found in the medical records according to the ADA. After
a patient was found to have the diagnosis of T2DM, the
record was reviewed to see if HbA1c levels were recorded
to be included in the study. Only those with HbA1c
measurements taken within the first 24 hours were
included. The inclusion criteria for an AMI was that each
case was validated using the widely accepted diagnostic
definition developed by the World Health Organization
(WHO) [4] This definition requires that at least two out of
three criteria be present for the confirmation of AMI. This
uses information from the patient’s clinical history, serum
enzyme elevations, and serial ECG findings. This
secondary data analysis was conducted in patients
presenting with an incidental (first time) AMI who had
HbA1c measures taken within the first 24 hours of hospital
admission and reported in the medical chart. We included
all patients with ICD-9 codes: 410-414; specifically: New
MI, 411: Other acute/sub-acute forms ischemic heart
disease, 412: Old MI, 413 Angina pectoris, and 414: Other
forms of chronic ischemic heart disease, and excluded 412:
patients with previous MI. The records of any previous
hospitalizations for cardiovascular events were reviewed
when available and if past records indicated similar
presentation they were excluded from the study. We
excluded patients who did not meet the diagnosis criteria
for DM (n=1,138) as stated above, missing key variables
of the study, had ECG changes consistent with previous
MI, documented history of MI, patients who developed
AMI from any procedural events during their hospital stay,

and any cardiopulmonary complication the arises after 24
hours of initial hospital arrival. The cardiopulomanary
complications that were included in our study was atrial
fibrillation, ventricular tachycardia, ventricular fibrillation,
cardiac arrest, pulmonary infarction, pulmonary edema,
respiratory failure, and stroke. All of these complications
were documented in the patient’s medical chart and had to
be within 24 hours of admission The study population
consisted of Puerto Ricans (a mostly Hispanic population)
men and women with T2DM living on the Island who
were hospitalized for an incidental AMI. In the database,
there were 2,204 patients with an AMI during 2007, 2009,
and 2011. A total of 1,470 patients were excluded for not
having an incidental AMI or not being diagnosed with
T2DM. Out of the remaining 734 patients, 532 were
excluded, as they did not have information on HbA1c
measurement. Thus, 202 patients comprised our study
population [10].
The study population was divided into two groups
according to their HbA1C level: controlled DM (HbA1c <7)
and uncontrolled DM (HbA1c >7). The covariables that
were analyzed in this study were age, gender,
hypertension, obesity (defined as BMI>30kg/m2),
hyperlipidemia, chronic obstructive pulmonary disease
(COPD), current cigarette smokers, and insurance status.
These variables were selected because they were related to
both HbA1c levels as well as to AMI complications.
All data were obtained from medical documentation of
each individual patient that was entered into the database
system. Participants have been appropriately de-identified
to maintain minimal risk exposure of sensitive information,
which was our main concern when obtaining the data for
our study.

2.3. Statistical Analysis
STATA version 14.0 was used for the statistical
analysis. The medical records of patients discharged with
a diagnosis consistent with AMI were reviewed utilizing a
standardized electronic data abstraction form, which has
been adapted to use in Puerto Rico from the Worcester
Heart Failure Study. Data were captured electronically
utilizing the REDCapTM web application exclusively
designed for research studies that allows secure online
management of surveys and databases. For the purpose of
present analysis, patients were divided into controlled
(HbA1c ≤7%) and uncontrolled DM (, HbA1c >7%) based
on admission HbA1c. Categorical variables are presented
as percentage and number of patients and the continuous
variable are presented as mean ± standard deviation.
Baseline characteristics of the two groups were compared
using the χ2 test, t student test, and the Fisher exact test as
appropriate. Logistic regression models (univariate and
multivariate analysis) were used to test the association
between the independent variable and the outcome variable,
which is in-hospital mortality and cardiopulmonary
complications. The Hosmer-Lemeshow test was used to
test for the goodness-of-fit of the logistic regression
models. The multivariate logistic regression model was
adjusted for sex, age, body mass index (BMI),
hypertension, hyperlipidemia, chronic obstructive
pulmonary disease (COPD), current smokers, insurance
status, and age. A p-value <0.05 was considered as
statistically significant.
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3. Results
Table 1 presents the characteristics of the study
participants according to DM control (HbA1C<7% versus
HbA1C≥7%). The only characteristic that was statistically
significantly different was that the patients in the
uncontrolled DM group were younger than those in the
group with controlled DM (mean age 65.2 vs. 71.1 years;
p-value 0.002). No statistically significant differences
were found in the distribution of gender, obesity
(BMI>30kg/m2), hyperlipidemia, hypertension, COPD,
current smokers, or insurance between the two groups.
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The association between HbA1c, mortality and
cardio-pulmonary complications among DM patients are
presented in Table 2. In the univariate analysis
uncontrolled DM patients were twice as likely to die or to
have complications than those that had DM controlled
(OR 2.1; 95% CI: 0.7-6.4). After adjustment for gender,
BMI>30 kg/m2, hyperlipidemia, hypertension, COPD,
current smokers, insurance status, and age the OR only
marginally changed and remained statistically nonsignificant (OR 2.4; 95% CI: 0.5-10.3). The OR for an
association between obesity and mortality was not
statistically significant after multivariate adjustment (OR
0.8; 95% CI 0.2-2.8).

Table 1. Characteristics of diabetes mellitus (DM) patients with first time acute myocardial infarction according to DM control in Puerto Rico
during 2007, 2009, and 2011
Controlled (HbA1C<7%)
Uncontrolled (HbA1C≥7%)
Characteristics
p-value
% (n)
% (n)
0.112
Sex
% (n
Male
47.0 (31)
58.8 (80)
Female
53.0 (35)
41.2 (56)
0.109
BMI1 >30 kg/m2
No
37.0 (17)
24.3 (27)
Yes
63.0 (29)
75.7 (84)
0.413
Hyperlipidemia
No
63.1 (41)
68.9 (93)
Yes
37.0 (24)
31.1 (42)
0.526
Hypertension
No
18.2 (12)
14.7 (20)
Yes
81.8 (54)
85.3 (116)
0.315
COPD2
No
93.9 (62)
89.6 (121)
Yes
6.1 (4)
10.4 (14)
0.564
Current Smoker
No
86.2 (56)
83.0 (112)
Yes
13.9 (9)
17.0 (23)
0.128
Insurance
No
30.3 (20)
20.6 (28)
Yes
70.0 (46)
79.4 (108)
71.1 (10.7)
65.2 (12.0)
0.002
Age (years)- mean (SD3)
1
Body Mass Index; 2Chronic Obstructive Pulmonary Disease; 3Standard Deviation.
Table 2. Unadjusted and adjusted odds ratios for the association between HbA1c, mortality and complications among diabetes mellitus patients
with first time acute myocardial infarction in Puerto Rico during 2007, 2009, and 2011
Unadjusted model (n=202)
Adjusted model (n=202)
Characteristics
OR (95% CI)
OR (95% CI)
HbA1c
Control
Reference
Reference
Uncontrolled
2.1 (0.7-6.4)
2.4 (0.5-10.3)
Sex
Male
Reference
Reference
Female
1.2 (0.5-3.1)
1.7 (0.5-5.6)
BMI1> 30 kg/m2
No
Reference
Reference
Yes
0.8 (0.3-2.6)
0.8 (0.2-2.8)
Hyperlipidemia
No
Reference
Reference
Yes
1.5 (0.6-4.0)
2.0 (0.6-6.8)
Hypertension
No
Reference
Reference
Yes
1.1 (0.3-4.0)
0.7 (0.1-3.6)
COPD2
No
Reference
Reference
Yes
0.5 (0.07-4.3)
0.3 (0.03-3.0)
Current Smoker
No
Reference
Reference
Yes
1.4 (0.4-4.4)
2.6 (0.6-12.3)
Insurance
Yes
Reference
Reference
No
0.8 (0.2-2.5)
0.7 (0.2-3.1)
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Out of 734 DM patients with an AMI, only 202 had
their HbA1c levels measured (Table 3). DM patients
without HbA1C measurement seemed to have a higher
prevalence of mortality and complications (12.8%)
compared to measured patients (9.9%). However, these
results were not statistically significant (p=0.283). There
was a higher prevalence of COPD in the group where
HbA1c was measured (9.0%) compared to those with no
HbA1c measured (4.7%; p-value=0.031). Furthermore, the

prevalence of obesity (BMI>30 kg/m2) was higher in the
group who had HbA1c measured (71.9%) compared to
those who were not measured (62.8%; p-value=0.037).
There was a higher distribution of patients with insurance
in the group where HbA1c was measured (76.2%)
compared to those who did not have measurement (66.4%;
p-value=0.010). There was no statistical significant
difference in the rest of the characteristics studied.

Table 3. Characteristics of all previously diabetes mellitus patients with first time acute myocardial infarction according to whether HbA1C
was measured or not in Puerto Rico during 2007, 2009, and 2011
HbA1c measured (N=202
No HbA1c measured (N=532)
Characteristics
p-value
% (n)
% (n)
0.283
Mortality and complications
No
90.1 (182)
87.2 (464)
Yes
9.9 (20)
12.8 (68)
0.670
Sex
Male
54.9 (111)
53.2 (283)
Female
45.1 (91)
46.8 (249)
0.037
BMI1 > 30 kg/m2
No
28.0 (44)
37.3 (165)
Yes
71.9 (113)
62.8 (278)
0.951
Hyperlipidemia
No
67.0 (134)
67.2 (353)
Yes
33.0 (66)
32.8 (172)
0.642
Hypertension
No
15.8 (32)
14.5 (77)
Yes
84.8 (170)
85.5 (455)
0.031
COPD2
No
91.0 (183)
95.3 (503)
Yes
9.0 (18)
4.7 (25)
0.113
Current Smoker
No
84.0 (168)
88.4 (465)
Yes
16.0 (32)
11.6 (61)
0.010
Insurance
No
23.8 (48)
33.7 (179)
Yes
76.2 (154)
66.4 (353)
67.0 (11.9)
67.9 (12.3)
0.430
Age-mean (SD3)
1
Body Mass Index; 2Chronic Obstructive Pulmonary Disease; 3Standard Deviation.

4. Discussion
Even though our study found that AMI patients with
uncontrolled DM had a two-fold increased risk of
mortality and cardiopulmonary complications compared to
controlled DM, this risk increase was not statistically
significant.
A possible explanation may be a power issue and future
studies may adjust for this with a larger study population.
This may reveal whether poor DM control is associated
with in-hospital mortality and cardio-pulmonary
complications. The assessment of chronic glycemic
control is highly variable among patients with AMIs and
DM. Because much of this variability occurs at the
hospital level, the evaluation of DM control could
represent an additional quality indicator and an
opportunity to advance patient-centered AMI care [4].
Every year over 735,000 Americans citizens have an AMI
and people with known DM have an increased risk [6,7].
In addition, it might be desirable to achieve HbA1c as
close to the normal glycemic range as possible [8].
Poor DM control has shown to increase the risk of
mortality through several mechanisms [11]. When glucose

levels are chronically elevated they damage blood vessels
and make them more susceptible to atherosclerosis build
up. This causes people to develop atherosclerosis at an
early age, leading to hypertension and coronary artery
disease [4]. DM patients are also more prone to develop
dyslipidemia. Their LDL particles are smaller then nondiabetics making it easier to penetrate vessels. This makes
the particles more susceptible to oxidation and damage [4].
Higher HbA1c was associated with poor glycol-metabolic
control, older patients, obesity, hypertension, Killip's
class>1, tachycardia, initial bundle branch block, atrial
fibrillation, and higher mortality during follow-up
[5]. These patients with disturbed glucose metabolism
had worse early outcomes, characterized by progressive
increased rates of in-hospital mortality according to HbA1c.
In hospital mortality was 14% higher in patients with
HbA1c >6.4% [7]. Diabetes patients with low or high
HbA1c are at higher risk of all cause mortality compared
wit patients with relatively moderate Hba1c levels [8]. This
compared to our study by looking for similar outcomes in
terms of mortality and cardiopulmonary complications.
Our study also tried to looks for an increased risk of
mortality and cardiopulmonary complications based on
Hba1c levels. But our odds ratio was not statistically
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significant and we had a wide confidence interval showing
a lack of precision in our study.
Previous studies have shown that elevated glucose
levels increase the risk of mortality after an AMI in both
diabetic and non-diabetic patients [17]. Both DM and nonDM patients had significantly higher plasma glucose
levels, while HbA1c-adjusted levels were not associated
with post-AMI prognosis [19]. Our study did not analyze
admission glucose but rather HbA1c levels within 24 hours
of admission. We did not find any significant evidence to
support the claim that DM patients with AMI had
increased mortality and complications. We also did not
evaluate medical records past the initial 24 hours of
hospital stay to evaluate long-term prognosis for patients
with controlled and uncontrolled HbA1c levels. A
secondary data analysis of The National Cardiovascular
Data Registry (NCDR) observed no association between
HbA1C and mortality in patients with diabetes presenting
with AMI [18]. In a multivariable regression, they
observed no association between low or high HbA1c [18].
Similar to their study we did not find any statistically
significant association between HbA1c and mortality and
complications. As their study, our study had similar
limitations DM patients with AMI did not have
information on HbA1c measurement (59%). In another
study Hba1c and blood glucose was measured within 3
hours of admission of an AMI to evaluate for myocardial
perfusion abnormalities [15]. Patients with the highest
HbA1c (>8.5%) showed the highest morality, doublevessel, and triple-vessel disease compared to lower HbA1c
levels. We had similar outcomes in terms of mortality and
trying to relate it to chronic glycemic control [19]. But this
study had a follow up at four weeks and did not accurately
measure the immediate outcome for elevated HbA1c levels
as our study did. We also did not find any statistically
significant association between HbA1c and mortality as
this study did at the 4 week follow up. To detect
myocardial perfusion defects and relate it to mortality a
coronary angiography performed within 24 hours would
have been a better predictor to relate it to plasma glucose,
HbA1c, and mortality. Some studies used a different
definition of DM control [14,15] as our study used HbA1c
above 7% as uncontrolled DM, while their study used 8.5%.
The limitations of our study were small sample size and
limited number of outcomes. Out of a potential 2,204
patients with an AMI, only 202 had DM and HbA1c
measured within 24 hours of hospital admission. This
affected the power of our study to detect an association.
Since there was a low study population we completed a
non-responder analysis based on whether HbA1c was
measured (Table three). The results indeed showed that
the non-measured HbA1c patients had different profile
than those with measured HbA1c. The patients with HbA1c
measured were statistically significantly different in terms
of BMI>30 kg/m2 (p-value 0.037), have COPD (p-value
0.031), and have insurance (p-value 0.010) In addition to
small sample size we also had a limited number of
outcomes. Out of the 202 patients in our study population,
only 20 cases had complications. If a greater number of
complications were found in a study population it could
possibly change future management strategies for DM
patients with AMI. Despite not measuring glucose levels,
hyperglycemia could also affect mortality both acutely
and chronically. Follow up HbA1c levels should have been
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checked at monthly or yearly intervals to look for a
possible association with mortality, as it might be a
predictor of future mortality rather than short-term
prognosis. Finally, we were not able to assess whether
hypertension treatment or adecuate hypertension control
was associated with mortality due to a lack of this
particular information. Even though we did not find a
statistically significantly increased risk of being classified
as hypertensive, we are aware that due to the above
mentioned limitation, no conclusions can be made in
regard to a possible association between uncontrolled
hypertension and mortality

5. Conclusion
In conclusion, our findings suggest that AMI patients
with uncontrolled DM did not have an increased risk of
mortality and cardiopulmonary complications compared to
controlled DM. However, this needs further evaluation on
a larger study population in order to give more accurate
results evaluate DM patients. We recommend that all DM
patients with an AMI should have HbA1c measured to
estimate their risk, manage patient’s glycemic control
better, and possibly prevent future complications from
happening. In addition, other factors such as tobacco
consumption, hyperlipidemia, obesity, and hypertension
are important factors to be assessed and controlled for in
order to improve survival in AIM.”
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